NewsNation spoke with Dr. Jason Yaun, a pediatrician and professor at the University of Tennessee Health Science Center. A ...

All age groups in the United States are experiencing a "high severity" of influenza cases among all age groups for the first ...

The volume of recent flu infections and related hospitalizations is higher than what Sonoma County epidemiologists have ...

Dr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Here are four more respiratory illness updates: Nearly 1.7% of all deaths nationwide were attributed to flu, compared to approximately 1.5% from COVID-19. Influenza test positivity rose to 31.6%, ...

Dr. Smith is the president of the Tennessee Chapter of the American Academy of Pediatrics.

The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

In addition, more people died in Pennsylvania from the flu over the last two reporting periods than died of COVID-19, data ...

In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal ...

The flu just won’t quit this year. The virus seemed to peak after the December holidays in Massachusetts, headed back down, ...